Sedona-based Alternative to Meds Center highlights Glyphosate exposure, neurological health concerns, and more used in ...

Spurred by increasing public recognition of the dangers posed by police responses to mental health and substance use crises—particularly for people of color and individuals with ...

LOS ANGELES — While at a career fair, Ivan Parra took time to admire some of the STEM projects that were showcased. “There’s a lot of opportunities here — especially, there’s a booth about solar ...

Add Yahoo as a preferred source to see more of our stories on Google. The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) ...

Rhode Island Rep. Stephen Casey introduced a House bill on Feb. 27, which was referred to the House Corporations Committee, as reported by CFO Dive. Louisiana Rep. Gerald "Beau" Beaullieu IV pre-filed ...

ABA Committee Urges Inclusion of Alternative Licensure Pathways Language in Accreditation Standards The Standards Committee reviewed Standard 316 in light of the recent developments that several U.S.

Under the Innovation Regulation, institutions can propose pilot programs that would allow students to earn a bachelor’s degree in less than 120 credits. Massachusetts Gov. Maura Healey said in a ...

Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...

Sitting in the guidance counselor’s office enrolling in their core subjects is a rite of passage for everyone who passes through their awkward adolescent schooling experience. For some, their biggest ...

SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...

The last time I spoke about Omeros Corporation (OMER) it was in a Seeking Alpha article entitled "Omeros: FDA Appeal On Nasoplimab And Several 2023 Catalysts On Deck." Since then, it has faced several ...